Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1181 | KOD Kodiak Sciences Inc - Common Stock | 94.25 USD | +3.48% | -4.28% | +173.43% | +556.34% | 5.92 B USD | ||
| 1196 | LGND Ligand Pharmaceuticals Incorporated - Common Stock | 295.00 USD | +0.59% | -2.56% | +2.42% | +57.65% | 5.88 B USD | ||
| 1256 | ERAS Erasca, Inc. - Common Stock | 15.44 USD | +9.35% | +5.90% | -3.86% | +535.39% | 5.40 B USD | ||
| 1266 | MIRM Mirum Pharmaceuticals, Inc. - common stock | 81.39 USD | +0.93% | -2.93% | -16.97% | +16.06% | 5.28 B USD | ||
| 1271 | PTCT PTC Therapeutics, Inc. - Common Stock | 62.55 USD | -1.08% | -2.46% | -8.12% | -2.96% | 5.22 B USD | ||
| 1273 | SRRK Scholar Rock Holding Corporation - Common Stock | 42.16 USD | -0.09% | -8.67% | -26.45% | +40.44% | 5.13 B USD | ||
| 1276 | COGT Cogent Biosciences, Inc. - Common Stock | 30.09 USD | -0.17% | -4.75% | -14.25% | +92.02% | 5.22 B USD | ||
| 1304 | TVTX Travere Therapeutics, Inc. - Common Stock | 52.04 USD | -2.62% | -8.46% | -20.91% | +80.88% | 4.91 B USD | ||
| 1315 | CRSP CRISPR Therapeutics AG - Common Shares | 50.42 USD | -3.69% | -9.05% | -7.49% | -35.19% | 4.88 B USD | ||
| 1357 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 82.38 USD | -2.95% | -6.73% | -23.74% | +137.06% | 4.61 B USD | ||
| 1364 | DFTX Definium Therapeutics, Inc. - Common Shares | 34.17 USD | -2.62% | -9.12% | -9.65% | +126.14% | 4.59 B USD | ||
| 1429 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 39.23 USD | -0.86% | -3.09% | -8.83% | +157.58% | 4.26 B USD | ||
| 1439 | ADPT Adaptive Biotechnologies Corporation - Common Stock | 26.08 USD | -0.76% | -4.71% | +8.44% | +51.10% | 4.16 B USD | ||
| 1496 | RLAY Relay Therapeutics, Inc. - Common Stock | 17.42 USD | -2.95% | -5.79% | -7.14% | +183.25% | 3.82 B USD | ||
| 1506 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.02 USD | -0.90% | +2.80% | -8.85% | +74.64% | 3.73 B USD | ||
| 1510 | TNGX Tango Therapeutics, Inc. - Common Stock | 22.56 USD | +3.34% | -7.73% | -0.31% | +226.96% | 3.80 B USD | ||
| 1519 | ABCL AbCellera Biologics Inc. - Common Shares | 12.01 USD | -6.39% | -13.72% | +5.63% | +94.97% | 3.68 B USD | ||
| 1550 | VCYT Veracyte, Inc. - Common Stock | 43.58 USD | +0.97% | -1.38% | +1.85% | +18.10% | 3.50 B USD | ||
| 1552 | IDYA IDEAYA Biosciences, Inc. - Common Stock | 36.04 USD | -0.61% | -4.68% | -7.21% | +10.62% | 3.48 B USD | ||
| 1553 | XENE Xenon Pharmaceuticals Inc. - Common Shares | 36.16 USD | -0.69% | -7.12% | -38.75% | -11.35% | 3.50 B USD |
Nachrichten Biotechnology Stocks
Kymera Therapeutics: Raymond James startet Coverage mit „Outperform“-Rating
Raymond James startet Coverage für Nektar-Aktie mit "Market Perform"
Raymond James nimmt Coverage für Palisade Bio mit "Outperform" auf
Raymond James bestätigt Liquidia-Rating trotz rechtlicher Unsicherheiten
Ginkgo Bioworks gewährt NSF X-Labs Zugang zu autonomem Labor
AbCellera präsentiert Phase-1/2-Daten zu Medikamentenkandidaten gegen Menopause-Beschwerden
Quantum-Si: Nachweis von 19 Aminosäuren markiert wichtigen Meilenstein für Proteus-Plattform
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.79 | +16.26% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 28.00 | +11.38% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.54 | +10.60% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
ENLV Enlivex Ltd. - Ordinary Shares | 0.27 | -12.90% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |